Levosimendan: current status and future prospects

Current Opinion in Anaesthesiology
Sylvia Archan, Wolfgang Toller

Abstract

While patients with acute heart failure typically receive diuretics and vasodilators, contractile dysfunction and peripheral hypoperfusion also leads to a widespread use of inotropic agents despite the lack of evidence for efficacy or safety. Levosimendan, a calcium sensitizer and vasodilator, has been proposed to be superior to standard inotropes. In addition, further possible indications for levosimendan have been described, such as perioperative use, cardioprotection, cardiogenic shock, sepsis, and right ventricular dysfunction. The mortality benefit of levosimendan has not been confirmed in two recent trials but the substance improves symptoms, decreases brain natriuretic peptide and is effective during beta-blocker treatment. The use of levosimendan as an add-on therapy in acute heart failure has been encouraged as well as its perioperative use. Levosimendan may also be useful during right ventricular dysfunction and septic shock due to its favorable effects on splanchnic perfusion. Levosimendan is an established substance in the treatment of acute heart failure in several countries despite disappointing findings concerning a possible survival benefit in two recent clinical trials. Owing to its alternative mechanisms of ac...Continue Reading

References

Aug 11, 2000·European Journal of Heart Failure·UNKNOWN Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology
Nov 25, 2000·Journal of the American College of Cardiology·M S NieminenW J Remme
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Anju NohriaLynne Warner Stevenson
Jul 23, 2002·Lancet·F FollathUNKNOWN Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study
Dec 18, 2002·American Heart Journal·Andrew J BurgerUNKNOWN Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy
Jan 8, 2003·Circulation·Matti KivikkoWilson S Colucci
Mar 26, 2003·Journal of the American College of Cardiology·G Michael FelkerUNKNOWN OPTIME-CHF Investigators
May 6, 2004·International Journal of Clinical Pharmacology and Therapeutics·C LabriolaB Amantea
Oct 7, 2004·Journal of the American College of Cardiology·Adrian F HernandezJames G Jollis
Nov 20, 2004·Journal of Cardiovascular Pharmacology·Stjepan BarisinDinko Tonkovic
Jan 29, 2005·Anaesthesia and Intensive Care·W Plöchl, A Rajek
Mar 23, 2005·Circulation·Jonathan D Sackner-BernsteinKeith D Aaronson
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
Jan 18, 2006·Anaesthesia·B M EllgerT Brussel
Jan 19, 2006·American Journal of Physiology. Renal Physiology·Richard A ZagerChristine K Abrass
Jan 20, 2006·Critical Care : the Official Journal of the Critical Care Forum·Jan-Peter BraunClaudia Spies
Feb 7, 2006·Journal of Cardiothoracic and Vascular Anesthesia·Rex Joseph Morais
Feb 21, 2006·Wiener klinische Wochenschrift·Daniel HoeferGerhard Poelzl
Mar 2, 2006·Anesthesiology·Wolfgang G Toller, Christian Stranz
Mar 28, 2006·The Annals of Thoracic Surgery·Shahzad G Raja, Benson S Rayen
Apr 6, 2006·British Journal of Anaesthesia·L TritapepeP Pietropaoli
May 23, 2006·European Journal of Heart Failure·Athanasios TrikasChristodoulos Stefanadis
Jun 6, 2006·Journal of Cardiothoracic and Vascular Anesthesia·Emad Al-ShawafRiad Tarazi
Jun 21, 2006·The American Journal of Cardiology·Stamatis AdamopoulosDimitrios T Kremastinos
Jul 25, 2006·Heart, Lung & Circulation·Ahmet AkgulAdnan Cobanoglu
Sep 15, 2006·Critical Care Medicine·François KerbaulSerge Brimioulle
Sep 26, 2006·The Annals of Thoracic Surgery·Liisa M PetäjäRaili T Suojaranta-Ylinen
Oct 26, 2006·The Annals of Thoracic Surgery·Philippe-Primo CaimmiGiovanni Teodori

❮ Previous
Next ❯

Citations

Apr 16, 2009·Intensive Care Medicine·Patrick ScheiermannChristian Hofstetter
Dec 3, 2014·Emergency Medicine Clinics of North America·Joe Kanter, Peter DeBlieux
Dec 24, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Dinesh KumarRanju Bansal
Mar 26, 2015·Acute Cardiac Care·Elisabetta PalmeriniStefano Lunghetti
May 7, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Florian WeisBruno Reichart
Jun 21, 2011·Clinical Cardiology·Marcos F MinicucciLeonardo A M Zornoff
Mar 3, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Ravinesh MishraChirag Goda
Mar 14, 2014·JACC. Heart Failure·Milton PackerUNKNOWN REVIVE Heart Failure Study Group
Dec 14, 2016·Future Medicinal Chemistry·Jyoti SinghRanju Bansal
Sep 1, 2009·Journal of Environmental Management·C StoateC Ramwell
Feb 6, 2010·Circulation Research·Karin R Sipido, Peter Vangheluwe
Sep 13, 2008·Current Opinion in Critical Care·Antonis A Pitsis, Aikaterini N Visouli
May 11, 2010·The Journal of Trauma·Stefano BusaniMassimo Girardis
Nov 12, 2019·Future Medicinal Chemistry·Heba Abdelrasheed AllamRiham F George
Jun 9, 2009·Current Opinion in Anaesthesiology·Markku Salmenperä, Heidi Eriksson
May 28, 2021·Journal of Neurointerventional Surgery·Stefan WandererJürgen Konczalla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.